Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy

NCT05751915 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.

NCT NCT05751915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05751915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
Lead sponsor
Genetesis Inc.
Phase
Observational
Overall status
Unknown status
Start date
May 23, 2023
Completion date
January 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary allograft vasculopathy (cav)